Prevention of type 2 diabetes mellitus
Abstract
The current global epidemic of diabetes mellitus type 2 (T2DM) is primarily a consequence of overweight/ obesity and a sedentary lifestyle. The prevention or modification of progressive insulin resistance is the key to preventing the development of diabetes. Along with
Diabetic foot syndrome: interdisciplinary approach to disease management
Abstract
The diabetic foot problems are discussed in the manuscript: definition, economic and social burden. The history of a team approach to management of the diabetic foot and effectiveness of its implementation on inpatient and outpatient care are analyzed.
The possibilities of clinical use of glibenclamide in the 21st century
Abstract
GLibencLamide is a drug of the II generation of sulfonylureas and is one of the most popular and studied of gLucose-Lowering drugs, which is more than 60 years is used in many countries as a reLiabLe and time-tested means of therapy of diabetes of type 2. In experimentaL and
The place of Diabeton MR in the modern treatment of diabetes mellitus type 2
Abstract
For many years, suLfonyLureas have been the foundation in the treatment of diabetes meLLitus type 2, despite the emergence of new antidiabetic drugs, the addition of suLfonyLureas is stiLL a variant of the second Line of therapy in addition to monotherapy with metformin. The
Adherence of patients to the metformin therapy with prolonged action (Glucophage® Long) in real clinical practice in the Russian Federation
Abstract
Immediate - release metformin (metformin IR) therapy of type 2 diabetes mellitus (DM2) usually prescribed for 2 or 3 times a day. The extended - release formulation (metformin XR) has been developed to allow once - daily dosing which may provide higher compliance and more
Efficacy and safety of sitagliptin/metformin fixed-dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double-blind study
Abstract
EarLy initiation of combination therapy using antihypergLycemic agents is recommended for treating type 2 diabetes (T2D). The present muLticenter doubLe - bLind randomized paraLLeL - group study examined the efficacy and safety of a sitagLiptin and metformin fixed - dose
Features of management of patients older than 85 years with type 2 diabetes mellitus in Moscow (according to the State Register of patients with diabetes)
Abstract
The problem of hypoglycemic therapy of eldery people over 85 years is discussed in this article. Eldery people often have many concomitant diseases including cardiovascular and cognitive problems, renal or hepatic failure. They have to take more than 5 different medicines
Influence of androgenic deficiency and the disbalance of the immune system on the formation of hydrochair exchanger disorders in men with obesity
Abstract
Androgen deficiency is actively discussed as one of the main pathogenetic factors in the formation of violations of carbohydrate metabolism in men, as well as the role of disorders of the adaptive immunity in the pathogenesis of metabolic diseases and their vascular
Features of natural autoimmunity in patients with diabetes mellitus
Abstract
At present, much attention is paid to research of various autoantibodies and their roLe in reguLation of physioLogicaL processes, especiaLLy in autoimmune diseases, incLuding diabetes meLLitus (DM). This articLe examines the spectrum of naturaL autoantibodies to organ -
Microcirculatory disorders and diabetic polyneuropathy relationship evaluation in T2DM. Hypergly-cemia factor in vascular and neurological impairment development
Abstract
In this study we applied digital capillaroscopy, vasography, stimulation electromyography methods in examination of patients with different glycemic control. The aim of the study: to evaluate the correlation between microcirculation parameters, endothelial
Aritmogene dilated cardiomyopathy in patient with subclinical hyperthyroidism
Abstract
Case history of dilated cardiomyopathy in patient with subclinical hyperthyroidism.